XTX Topco’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$723K Buy
54,145
+6,024
+13% +$80.4K 0.03% 859
2025
Q1
$490K Buy
+48,121
New +$490K 0.03% 1048
2024
Q3
Sell
-4,996
Closed -$228K 2348
2024
Q2
$228K Buy
+4,996
New +$228K 0.02% 1147